Screener
Bruker BRKR Bsi Biospin — Selling General And Administrative Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Bruker’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335226
| Line item | Three Months Ended June 30, 2026 / BSI Bio Spin | Three Months Ended June 30, 2026 / BSI CALID | Three Months Ended June 30, 2026 / BSI NANO | Three Months Ended June 30, 2026 / BEST | Three Months Ended June 30, 2026 / Total | Three Months Ended June 30, 2025 / BSI Bio Spin | Three Months Ended June 30, 2025 / BSI CALID | Three Months Ended June 30, 2025 / BSI NANO | Three Months Ended June 30, 2025 / BEST | Three Months Ended June 30, 2025 / Total |
|---|---|---|---|---|---|---|---|---|---|---|
| Total segment revenue | $195.7 | $310.3 | $261.3 | $74.2 | $841.5 | $195.3 | $285.8 | $252.1 | $66.3 | $799.5 |
| Segment expenses: | ||||||||||
| Cost of revenue | $94.1 | $126.1 | $123.7 | $59.8 | $403.7 | $108.1 | $125.6 | $125.6 | $52.3 | $411.6 |
| Selling, general and administrative | 38.4 | 79.3 | 68.6 | 5.8 | 192.1 | 40.9 | 76.9 | 72.7 | 5.7 | 196.2 |
| Research and development | 21.5 | 32.6 | 39.2 | 1.0 | 94.3 | 23.2 | 30.0 | 44.4 | 1.1 | 98.7 |
| Segment operating income | $41.7 | $72.3 | $29.8 | $7.6 | $151.4 | $23.1 | $53.3 | $9.4 | $7.2 | $93.0 |
| Reconciliation of Total operating income: | ||||||||||
| Corporate, elimination and other (a) | $32.8 | $21.1 |
ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Bruker's bsi biospin — selling general and administrative expense?
- Bruker (BRKR) reported bsi biospin — selling general and administrative expense of $38.4M in Q2 2026.
- How has Bruker's bsi biospin — selling general and administrative expense changed year-over-year?
- Bruker's bsi biospin — selling general and administrative expense decreased by 6.1% year-over-year, from $40.9M to $38.4M.
- What is the long-term trend for Bruker's bsi biospin — selling general and administrative expense?
- Over 3 years (2022 to 2025), Bruker's bsi biospin — selling general and administrative expense has grown at a 10.4% compound annual growth rate (CAGR), from $121M to $162.7M.
- What does bsi biospin — selling general and administrative expense mean?
- This captures the operating expenses incurred by the BioSpin segment for non-production activities, including sales, marketing, legal, and general corporate support. It reflects the overhead required to maintain the segment's market presence and administrative infrastructure. High levels relative to revenue may indicate aggressive expansion or inefficient administrative scaling.
Ask your AI about Bruker's bsi biospin — selling general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude